• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人雌激素受体显性负性形式的鉴定。

Identification of a dominant negative form of the human estrogen receptor.

作者信息

Wang Y, Miksicek R J

机构信息

Department of Pharmacological Sciences, State University of New York, Stony Brook 11794-8651.

出版信息

Mol Endocrinol. 1991 Nov;5(11):1707-15. doi: 10.1210/mend-5-11-1707.

DOI:10.1210/mend-5-11-1707
PMID:1779972
Abstract

Experiments were undertaken to characterize mRNAs coding for the estrogen receptor (ER) in the human breast cancer cell line T47D. We report here the isolation of cDNAs corresponding to three isoforms of this receptor in addition to a majority of wild-type clones. Sequence analysis showed that these isoforms are generated through alternative splicing. None of the alternatively spliced isoforms of ER is able to bind to an estrogen-responsive element (ERE) in a gel mobility shift assay in vitro or to activate transcription of a reporter gene containing an ERE in vivo. One isoform, ER delta E3, which harbors a deletion of exon 3 encoding the second zinc finger of the DNA-binding domain, inhibits estrogen-dependent transcription activation in a dominant negative fashion when it is cotransfected with the wild-type ER and reporter plasmid. It also inhibits DNA binding of wild-type ER in a gel mobility shift assay in vitro. Since ER delta E3 is not able to bind to its response element, the observed inhibitory effect probably occurs through protein-protein interactions. This could involve the formation of a heterodimer between mutant and wild-type receptors, competition for a limiting transcription factor, or both. These results may have implications for understanding the loss of estrogen responsiveness that frequently occurs in breast cancer.

摘要

开展实验以表征人类乳腺癌细胞系T47D中编码雌激素受体(ER)的mRNA。我们在此报告,除了大多数野生型克隆外,还分离出了与该受体三种同工型相对应的cDNA。序列分析表明,这些同工型是通过可变剪接产生的。在体外凝胶迁移率变动分析中,ER的可变剪接同工型均不能与雌激素反应元件(ERE)结合,在体内也不能激活含有ERE的报告基因的转录。一种同工型ER delta E3缺失编码DNA结合域第二个锌指的外显子3,当它与野生型ER和报告质粒共转染时,以显性负性方式抑制雌激素依赖性转录激活。它还在体外凝胶迁移率变动分析中抑制野生型ER的DNA结合。由于ER delta E3不能与其反应元件结合,观察到的抑制作用可能是通过蛋白质-蛋白质相互作用发生的。这可能涉及突变体和野生型受体之间异二聚体的形成、对有限转录因子的竞争,或两者兼有。这些结果可能对理解乳腺癌中频繁发生的雌激素反应丧失具有重要意义。

相似文献

1
Identification of a dominant negative form of the human estrogen receptor.人雌激素受体显性负性形式的鉴定。
Mol Endocrinol. 1991 Nov;5(11):1707-15. doi: 10.1210/mend-5-11-1707.
2
An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.一种雌激素受体α剪接变体对基因转录既有正向作用也有负向作用。
Mol Endocrinol. 2000 May;14(5):634-49. doi: 10.1210/mend.14.5.0460.
3
Identification of a variant estrogen receptor lacking exon 4 and its coexpression with wild-type estrogen receptor in ovarian carcinomas.卵巢癌中一种缺乏外显子4的变异雌激素受体的鉴定及其与野生型雌激素受体的共表达。
Clin Cancer Res. 1996 Dec;2(12):2029-35.
4
Differential subcellular distribution and transcriptional activity of sigmaE3, sigmaE4, and sigmaE3-4 isoforms of the rat estrogen receptor-alpha.大鼠雌激素受体α的sigmaE3、sigmaE4和sigmaE3-4亚型的亚细胞分布差异及转录活性
Mol Endocrinol. 2001 Jun;15(6):894-908. doi: 10.1210/mend.15.6.0642.
5
Powerful dominant negative mutants of the human estrogen receptor.人雌激素受体的强效显性负性突变体。
J Biol Chem. 1993 Jul 5;268(19):14026-32.
6
Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression.雌激素受体/Sp1复合物在雌激素诱导的热休克蛋白27基因表达中的作用。
Mol Endocrinol. 1996 Nov;10(11):1371-8. doi: 10.1210/mend.10.11.8923463.
7
Identification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cells.
Biochem Biophys Res Commun. 1996 Feb 27;219(3):766-72. doi: 10.1006/bbrc.1996.0308.
8
Discrimination of DNA response elements for thyroid hormone and estrogen is dependent on dimerization of receptor DNA binding domains.甲状腺激素和雌激素的DNA反应元件的区分取决于受体DNA结合结构域的二聚化。
Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5527-31. doi: 10.1073/pnas.89.12.5527.
9
Generation and characterization of a human osteosarcoma cell line stably transfected with the human estrogen receptor gene.稳定转染人雌激素受体基因的人骨肉瘤细胞系的建立与鉴定
J Bone Miner Res. 1995 May;10(5):769-81. doi: 10.1002/jbmr.5650100514.
10
A transcriptionally active estrogen receptor mutant is a novel type of dominant negative inhibitor of estrogen action.一种转录活性雌激素受体突变体是雌激素作用的新型显性负性抑制剂。
Mol Endocrinol. 1996 Dec;10(12):1519-26. doi: 10.1210/mend.10.12.8961262.

引用本文的文献

1
Alternative splicing is an FXRα loss-of-function mechanism and impacts energy metabolism in hepatocarcinoma cells.可变剪接是一种法尼醇X受体α(FXRα)功能丧失机制,并影响肝癌细胞的能量代谢。
J Biol Chem. 2025 Jan;301(1):108022. doi: 10.1016/j.jbc.2024.108022. Epub 2024 Nov 26.
2
Alternative promoters and splicing create multiple functionally distinct isoforms of oestrogen receptor alpha in breast cancer and healthy tissues.可变启动子和剪接在乳腺癌及健康组织中产生多种功能不同的雌激素受体α亚型。
Cancer Med. 2023 Sep;12(18):18931-18945. doi: 10.1002/cam4.6508. Epub 2023 Sep 7.
3
Estrogen Receptor Function: Impact on the Human Endometrium.
雌激素受体功能:对人子宫内膜的影响。
Front Endocrinol (Lausanne). 2022 Feb 28;13:827724. doi: 10.3389/fendo.2022.827724. eCollection 2022.
4
Expression and clinical implications of estrogen receptors in thoracic malignancies: a narrative review.雌激素受体在胸部恶性肿瘤中的表达及临床意义:一项叙述性综述
J Thorac Dis. 2021 Mar;13(3):1851-1863. doi: 10.21037/jtd-20-2277.
5
Estrogen signaling and the aging brain: context-dependent considerations for postmenopausal hormone therapy.雌激素信号传导与衰老大脑:绝经后激素治疗的情境依赖性考量
ISRN Endocrinol. 2013 Jul 7;2013:814690. doi: 10.1155/2013/814690. Print 2013.
6
Expression of a dominant negative estrogen receptor alpha variant in transgenic mice accelerates uterine cancer induced by the potent estrogen diethylstilbestrol.在转基因小鼠中表达显性负性雌激素受体α变体可加速由强效雌激素己烯雌酚诱导的子宫癌。
Reprod Toxicol. 2012 Dec;34(4):512-21. doi: 10.1016/j.reprotox.2012.08.005. Epub 2012 Aug 31.
7
Analysis of estrogen receptor isoforms and variants in breast cancer cell lines.乳腺癌细胞系中雌激素受体亚型及变体的分析
Exp Ther Med. 2011 May;2(3):537-544. doi: 10.3892/etm.2011.226. Epub 2011 Mar 10.
8
Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant.抑制表达 ERΔ3 的转基因小鼠中的 Neu 诱导的乳腺肿瘤发生,ERΔ3 是一种显性负性雌激素受体 α 变体。
Horm Cancer. 2012 Dec;3(5-6):227-39. doi: 10.1007/s12672-012-0122-x. Epub 2012 Sep 12.
9
Cytoplasmic estrogen receptor in breast cancer.乳腺癌细胞质雌激素受体。
Clin Cancer Res. 2012 Jan 1;18(1):118-26. doi: 10.1158/1078-0432.CCR-11-1236. Epub 2011 Oct 6.
10
Estrogen receptor mutations and changes in downstream gene expression and signaling.雌激素受体突变及下游基因表达和信号转导的改变。
Clin Cancer Res. 2010 May 15;16(10):2702-8. doi: 10.1158/1078-0432.CCR-09-1753. Epub 2010 Apr 28.